- Home
- KINS vs STIM Comparison
KINS vs STIM Comparison
Compare KINS & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KINS
- STIM
- Stock Information
- Founded
- KINS 1886
- STIM 2003
- Country
- KINS United States
- STIM United States
- Employees
- KINS N/A
- STIM N/A
- Industry
- KINS Property-Casualty Insurers
- STIM Medical/Dental Instruments
- Sector
- KINS Finance
- STIM Health Care
- Exchange
- KINS Nasdaq
- STIM Nasdaq
- Market Cap
- KINS 206.6M
- STIM 232.3M
- IPO Year
- KINS N/A
- STIM 2018
- Fundamental
- Price
- KINS $15.65
- STIM $3.34
- Analyst Decision
- KINS Strong Buy
- STIM Buy
- Analyst Count
- KINS 1
- STIM 4
- Target Price
- KINS $6.50
- STIM $6.00
- AVG Volume (30 Days)
- KINS 324.5K
- STIM 884.9K
- Earning Date
- KINS 08-11-2025
- STIM 08-11-2025
- Dividend Yield
- KINS N/A
- STIM N/A
- EPS Growth
- KINS 5417.04
- STIM N/A
- EPS
- KINS 1.60
- STIM N/A
- Revenue
- KINS $169,875,701.00
- STIM $89,448,000.00
- Revenue This Year
- KINS $40.63
- STIM $104.65
- Revenue Next Year
- KINS $6.92
- STIM $10.69
- P/E Ratio
- KINS $9.80
- STIM N/A
- Revenue Growth
- KINS 18.52
- STIM 22.16
- 52 Week Low
- KINS $4.65
- STIM $0.52
- 52 Week High
- KINS $22.40
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- KINS 50.57
- STIM 36.21
- Support Level
- KINS $14.62
- STIM $3.11
- Resistance Level
- KINS $15.88
- STIM $3.61
- Average True Range (ATR)
- KINS 0.58
- STIM 0.20
- MACD
- KINS 0.12
- STIM 0.01
- Stochastic Oscillator
- KINS 76.30
- STIM 36.76
About KINS Kingstone Companies Inc.
Kingstone Companies Inc is a multi-line regional property and casualty insurance holding company. It offers insurance policies to small and mid-sized businesses as well as to individuals.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.